Novo Nordisk sues medical spas, wellness clinics, and pharmacies for selling impure semaglutide products.
Novo Nordisk, the maker of weight-loss drug Wegovy, has filed nine lawsuits against medical spas, wellness clinics, and pharmacies for allegedly selling impure products claiming to contain semaglutide, the active ingredient in its weight loss and diabetes drugs. The Danish company claims one product had no trace of the drug, while others had impurities up to 33%. Novo Nordisk first filed lawsuits over the sale of copycat versions of semaglutide last June.
May 30, 2024
4 Articles